Increasing Efficacy of Treatment in Patients with Steatohepatitis
This paper presents the results of a study of patients with nonalcoholic steatohepatitis, alcoholic steatohepatitis, and drug-induced liver injury. In patients with liver injury, changes in intestinal microflora were marked. After a combination therapy of this pathology with L-ornithine L-aspartate and symbiotic, an improvement of biochemical, clinical indicators was observed, as well as a decrease in fatty degeneration, reduction of elastographic indicators of liver fibrosis. The introduction of the drug formulation L-ornithine L-aspartate and symbiotic in the complex of conservative treatment of steatohepatitis help to prevent complications and increase the treatment efficacy of these diseases.
Bataller R., Gao B. Liver fibrosis in alcoholic liver disease // Semin. Liver Dis. 2015; 35: 146.
Baykova I.E., Nikitin I.G. [Drug liver] // Ross. Med. Zhurn. 2009; 1. — Article in Russian.
Bueverov A.O. et al. [Essential phospholipids in the treatment of mixed origin steatohepatitis] // Klin. perspekt. gastroenterol. gepatol. 2008; 1. — Article in Russian.
Weiler S., Merz M., Kullak-Ublick G.A. Drug-induced liver injury: the dawn of biomarkers? // F1000Prime Rep. 2015; 7: 34.
Drapkina О.М., Korneeva O.H., Ivashkin V.T. [Therapy of nonalcoholic steatohepatitis and metabolic syndrome: focus on essential phospholipids] // Lechaschiy Vrach 2010; 2. — Article in Russian.
Gerok V., Blum Kh.E. [Liver and biliary system], M.: МЕDpress-inform, 2009, p. 199. — Article in Russian.
Gong G. et al. Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats // PLoS One 2014; 9: e89450.
Khomeriki S.G., Khomeriki N.M. [Alcoholic liver disease: pathogenesis, morphological manifestations, differential diagnosis and pathogenetic approaches to therapy] // Gastroenterologiya 2012; 1. — Article in Russian.
Machado M.V., Cortez-Pinto H. Non-alcoholic fatty liver disease: what the clinician needs to know // World J. Gastroenterol. 2014; 20: 12956.
Neuman M.G. et al. Alcoholic and non-alcoholic steatohepatitis // Exp. Mol. Pathol. 2014; 97: 492.
Polunina T.E., Maev I.V. [Nonalcoholic fatty liver disease: epidemiology, pathogenesis, diagnosis, treatment] // Gastroenterologiya 2012; 1. — Article in Russian.
Velkov V.V. [Non-invasive biomarkers of fibrosis. Good-bye, biopsy?] // Kliniko-laboratornyy consilium 2009; 30. — Article in Russian.
Weismuller T.J., Lankisch T.O. [Biliary diseases — new insights and developments] // Dtsch. Med. Wochenschr. 2011; 136: S713. — Article in German.
Copyright (c) 2016 ACTUAL INFECTOLOGY
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2020